Development and Characterization of Recombinant Vesicular Stomatitis Virus (rVSV)-based Bivalent Vaccine Against COVID-19 Delta Variant and Influenza Virus
Z. Ao, M. Jing Ouyang, T. A. Olukitibi, B. Warner, R. Vendramelli, T. Truong, M. Zhang, S. Kung, K. R. Fowke, D. Kobasa, X. Yao
This study develops and tests a bivalent rVSV vaccine targeting SARS-CoV-2 Delta and influenza, showing strong immune responses and protection in animal models.
bioRxiv · Dec 14, 2021 · PreprintMicrobiology